Skip to Content
Be ready for a severe allergy emergency. Read more >>

Cromolyn ophthalmic Pregnancy and Breastfeeding Warnings

Cromolyn ophthalmic is also known as: Crolom, Opticrom

Cromolyn ophthalmic Pregnancy Warnings

Animal studies have revealed no evidence of teratogenicity with doses 205 times the maximum human dose. Increased fetal resorption and decreased fetal weight were observed at high parenteral doses that resulted in maternal toxicity. There are no controlled data in human pregnancy. AU TGA pregnancy category A: Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug should be used during pregnancy only if clearly needed. AU TGA pregnancy category: A US FDA pregnancy category: B

See references

Cromolyn ophthalmic Breastfeeding Warnings

Use is considered acceptable; caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comment: To limit systemic absorption, apply pressure to the tear duct at the corner of the eye for at least 1 minute after eye drop instillation; blot excess solution with tissue.

Maternal systemic absorption is expected to be very low. While it is unknown if this drug is excreted into milk, if excreted it would be poorly absorbed from the infant's gastrointestinal tract. The National Heart, Lung and Blood Institute, National Asthma Education, and Prevention Program Asthma and Pregnancy Working Group consider this drug to be acceptable during breastfeeding.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. Cerner Multum, Inc. "Australian Product Information." O 0
  3. "Product Information. Cromolyn Sodium Ophthalmic (cromolyn ophthalmic (sodium cromoglycate ophthalmic))." Akorn Inc, Buffalo Grove, IL.

References for breastfeeding information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. "Product Information. Cromolyn Sodium Ophthalmic (cromolyn ophthalmic (sodium cromoglycate ophthalmic))." Akorn Inc, Buffalo Grove, IL.
  4. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide